Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

por Barrios, Carlos H., Liu, Mei-Ching, Lee, Soo Chin, Vanlemmens, Laurence, Ferrero, Jean-Marc, Tabei, Toshio, Pivot, Xavier, Iwata, Hiroji, Aogi, Kenjiro, Lugo-Quintana, Roberto, Harbeck, Nadia, Brickman, Marla J., Zhang, Ke, Kern, Kenneth A., Martin, Miguel
Publicado 2010